Ipsen in the UK

Ipsen was first established in the UK in 1981. Today, the UK forms part of a critical and growing global network. It is one of our core operating hubs alongside Cambridge, USA and Paris, France. Our three UK sites are an important part of our international operations, helping to drive the Ipsen vision of innovation for patient care.

Improving the lives of patients is what drives us

Over the past four decades, Ipsen has cemented a strong presence in the UK, currently employing over 700 professionals across three sites: Oxford (Milton Park), Slough, and Wrexham. 

Our organisation spans the entire value chain in the UK: research and development (R&D), manufacturing and distribution, plus commercial operations. The UK contributes significantly to our business, with global specialised toxin production taking place at our site in Wrexham, research programmes being conducted at Milton Park, and a range of commercial and corporate activities and functions housed in our Slough site.

Our sites in the UK

At Ipsen, we strive to be a creative and like-minded partner of choice. We believe that achieving the best results for patients depends on our ability to work effectively and ethically in partnership with those around us, including healthcare professionals, the NHS, patient groups, policy makers and government.

Our partnership and contributions

ALL-GB-000681

December 2021

© Ipsen Group 2021